Incyte price target raised to $101 from $90 at Barclays

Barclays analyst Peter Lawson raised the firm’s price target on Incyte (INCY) to $101 from $90 and keeps an Overweight rating on the shares post the Q3 report. The company offered a “solid” commercial update with product beats for Jakafi, Opzelura and continued momentum for Niktimvo launch, the analyst tells investors in a research note.